<VariationArchive VariationID="836554" VariationName="NM_016122.3(CEP83):c.1234_1237del (p.Lys412fs)" VariationType="Deletion" Accession="VCV000836554" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="840459" VariationID="836554">
      <GeneList>
        <Gene Symbol="CEP83" FullName="centrosomal protein 83" GeneID="51134" HGNC_ID="HGNC:17966" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="94265662" stop="94460454" display_start="94265662" display_stop="94460454" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="94702055" stop="94853763" display_start="94702055" display_stop="94853763" Strand="-" />
          </Location>
          <OMIM>615847</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_016122.3(CEP83):c.1234_1237del (p.Lys412fs)</Name>
      <CanonicalSPDI>NC_000012.12:94367899:CTTTC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="94367900" stop="94367903" display_start="94367900" display_stop="94367903" variantLength="4" positionVCF="94367899" referenceAlleleVCF="ACTTT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="94761676" stop="94761679" display_start="94761676" display_stop="94761679" variantLength="4" positionVCF="94761675" referenceAlleleVCF="ACTTT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>K308fs</ProteinChange>
      <ProteinChange>K337fs</ProteinChange>
      <ProteinChange>K412fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.94761677_94761680del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.94761677_94761680del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.94367901_94367904del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.94367901_94367904del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_051825.1" sequenceAccession="NG_051825" sequenceVersion="1" change="g.97086_97089del">
            <Expression>NG_051825.1:g.97086_97089del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042399.2" sequenceAccession="NM_001042399" sequenceVersion="2" change="c.1234_1237del">
            <Expression>NM_001042399.2:c.1234_1237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035858.1" sequenceAccession="NP_001035858" sequenceVersion="1" change="p.Lys412fs">
            <Expression>NP_001035858.1:p.Lys412fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346457.2" sequenceAccession="NM_001346457" sequenceVersion="2" change="c.1234_1237del">
            <Expression>NM_001346457.2:c.1234_1237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333386.1" sequenceAccession="NP_001333386" sequenceVersion="1" change="p.Lys412fs">
            <Expression>NP_001333386.1:p.Lys412fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346458.2" sequenceAccession="NM_001346458" sequenceVersion="2" change="c.922_925del">
            <Expression>NM_001346458.2:c.922_925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333387.1" sequenceAccession="NP_001333387" sequenceVersion="1" change="p.Lys308fs">
            <Expression>NP_001333387.1:p.Lys308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001346459.2" sequenceAccession="NM_001346459" sequenceVersion="2" change="c.922_925del">
            <Expression>NM_001346459.2:c.922_925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001333388.1" sequenceAccession="NP_001333388" sequenceVersion="1" change="p.Lys308fs">
            <Expression>NP_001333388.1:p.Lys308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368037.1" sequenceAccession="NM_001368037" sequenceVersion="1" change="c.1234_1237del">
            <Expression>NM_001368037.1:c.1234_1237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354966.1" sequenceAccession="NP_001354966" sequenceVersion="1" change="p.Lys412fs">
            <Expression>NP_001354966.1:p.Lys412fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368038.1" sequenceAccession="NM_001368038" sequenceVersion="1" change="c.1234_1237del">
            <Expression>NM_001368038.1:c.1234_1237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354967.1" sequenceAccession="NP_001354967" sequenceVersion="1" change="p.Lys412fs">
            <Expression>NP_001354967.1:p.Lys412fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368039.1" sequenceAccession="NM_001368039" sequenceVersion="1" change="c.922_925del">
            <Expression>NM_001368039.1:c.922_925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354968.1" sequenceAccession="NP_001354968" sequenceVersion="1" change="p.Lys308fs">
            <Expression>NP_001354968.1:p.Lys308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368040.1" sequenceAccession="NM_001368040" sequenceVersion="1" change="c.922_925del">
            <Expression>NM_001368040.1:c.922_925del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354969.1" sequenceAccession="NP_001354969" sequenceVersion="1" change="p.Lys308fs">
            <Expression>NP_001354969.1:p.Lys308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368041.1" sequenceAccession="NM_001368041" sequenceVersion="1" change="c.1009_1012del">
            <Expression>NM_001368041.1:c.1009_1012del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354970.1" sequenceAccession="NP_001354970" sequenceVersion="1" change="p.Lys337fs">
            <Expression>NP_001354970.1:p.Lys337fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016122.3" sequenceAccession="NM_016122" sequenceVersion="3" change="c.1234_1237del" MANESelect="true">
            <Expression>NM_016122.3:c.1234_1237del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057206.2" sequenceAccession="NP_057206" sequenceVersion="2" change="p.Lys412fs">
            <Expression>NP_057206.2:p.Lys412fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_160432.1" sequenceAccession="NR_160432" sequenceVersion="1" change="n.1987_1990del">
            <Expression>NR_160432.1:n.1987_1990del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="780500128" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016122.3(CEP83):c.1234_1237del (p.Lys412fs) AND Nephronophthisis 18" Accession="RCV001037716" Version="5">
        <ClassifiedConditionList TraitSetID="16374">
          <ClassifiedCondition DB="MedGen" ID="C3890591">Nephronophthisis 18</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016122.3(CEP83):c.1234_1237del (p.Lys412fs) AND Nephronophthisis" Accession="RCV003483757" Version="1">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-12-06" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23530209</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24882706</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="16374" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21233" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 18</ElementValue>
                <XRef ID="MONDO:0014374" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP18</ElementValue>
                <XRef Type="MIM" ID="615862" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C3890591" DB="MedGen" />
              <XRef ID="MONDO:0014374" DB="MONDO" />
              <XRef Type="MIM" ID="615862" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7901654" SubmissionDate="2023-12-29" DateLastUpdated="2024-01-26" DateCreated="2024-01-26">
        <ClinVarSubmissionID localKey="nvtapin_pin_26252" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004228668" DateUpdated="2024-01-26" DateCreated="2024-01-26" Type="SCV" Version="1" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpreted as Pathogenic and reported on 12-16-2019 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">60</Age>
              <Age Type="maximum" age_unit="years">69</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2019-12-16" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <Method>
              <Description>Sanger Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2020-02-01" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000504" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000479" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP83" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016122.2:c.1234_1237del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14120880</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2366313" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6668507|MedGen:C3890591" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001201144" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23530209</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24882706</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CEP83 are known to be pathogenic (PMID: 23530209, 24882706). This variant has not been reported in the literature in individuals with CEP83-related conditions. This variant is present in population databases (rs780500128, ExAC 0.001%). This sequence change creates a premature translational stop signal (p.Lys412Trpfs*37) in the CEP83 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP83" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.94761676_94761679del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3890591" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2366313" TraitType="Disease" MappingType="XRef" MappingValue="C3890591" MappingRef="MedGen">
        <MedGen CUI="C3890591" Name="Nephronophthisis 18" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901654" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901654" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000479" MappingRef="HP">
        <MedGen CUI="C0035300" Name="Abnormal retinal morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901654" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000504" MappingRef="HP">
        <MedGen CUI="C4025846" Name="Abnormality of vision" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

